Literature DB >> 16962155

Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.

Gyoung Nyoun Kim1, C Yong Kang.   

Abstract

The matrix (M) protein of vesicular stomatitis virus (VSV) plays significant roles in the replication of VSV through its involvement in the assembly of virus particles as well as by facilitating the evasion of innate host cell defense mechanisms. The presence of methionine at position 51 (M51) of the matrix (M) protein of the VSV Indiana serotype (VSV(Ind)) has been proven to be crucial for cell rounding and inhibition of host cell gene expression. The M protein of VSV(Ind) with the substitution of M51 with arginine (R:M51R) results in the loss of inhibitory effects on host cell gene expression. The VSV(Ind) expressing the M(M51R) protein became the attractive oncolytic virus which is safer and more tumor-specific because the normal cells can clear the mutant VSV(Ind) easily but tumor cells are susceptible to the virus because a variety of tumor cells lack innate antiviral activities. We have studied the role of the methionines at positions 48 and 51 of the M protein of the New Jersey serotype of VSV (VSV(NJ)) in the induction of cytopathic effects (CPE) and host cell gene expression. We have generated human embryonic kidney 293 cell lines inducibly expressing M proteins with M to R mutations at positions 48 and 51, either separately or together as a double mutant, and examined expression of heat shock protein 70 (HSP70) as an indicator of host cell gene expression. We have also generated recombinant VSV(NJ) encoding the mutant M proteins M(M48R) or M(M48R+M51R) for the first time and tested for the expression of HSP70 in infected cells. Our results demonstrated that the M51 of VSV(NJ) M proteins has a major role in cell rounding and in suppressing the host cell gene expression either when the M protein was expressed alone in inducible cell lines or when expressed together with other VSV proteins by the recombinant VSV(NJ). Amino acid residue M48 may also have some role in cell rounding and in the inhibitory effects of VSV(NJ) M, which was demonstrated by the fact that the cell line expressing the double substitution mutant M(M48R+M51R) exhibited the least cytopathic effects and the least inhibitory effect on host cell gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962155     DOI: 10.1016/j.virol.2006.07.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.

Authors:  Gyoung Nyoun Kim; Kunyu Wu; Jiho Patrick Hong; Zain Awamleh; C Yong Kang
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

2.  The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.

Authors:  Melissa A Cobleigh; Clinton Bradfield; Yuanjie Liu; Anand Mehta; Michael D Robek
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells.

Authors:  Robert S Bayne; Shelby Puckett; Lindsey Ulkus Rodrigues; Scott D Cramer; Jingyun Lee; Cristina M Furdui; Jeff W Chou; Lance D Miller; David A Ornelles; Douglas S Lyles
Journal:  Mol Ther Oncolytics       Date:  2020-05-20       Impact factor: 7.200

4.  A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.

Authors:  Gyoung Nyoun Kim; Jung-Ah Choi; Kunyu Wu; Nasrin Saeedian; Eunji Yang; Hayan Park; Sun-Je Woo; Gippeum Lim; Seong-Gyu Kim; Su-Kyeong Eo; Hoe Won Jeong; Taewoo Kim; Jae-Hyung Chang; Sang Hwan Seo; Na Hyung Kim; Eunsil Choi; Seungho Choo; Sangkyun Lee; Andrew Winterborn; Yue Li; Kate Parham; Justin M Donovan; Brock Fenton; Jimmy D Dikeakos; Gregory A Dekaban; S M Mansour Haeryfar; Ryan M Troyer; Eric J Arts; Stephen D Barr; Manki Song; C Yong Kang
Journal:  PLoS Pathog       Date:  2021-12-16       Impact factor: 6.823

5.  Cytopathogenesis of vesicular stomatitis virus is regulated by the PSAP motif of M protein in a species-dependent manner.

Authors:  Takashi Irie; Yuliang Liu; Barbara S Drolet; Elena Carnero; Adolfo García-Sastre; Ronald N Harty
Journal:  Viruses       Date:  2012-09-19       Impact factor: 5.048

6.  Rhabdovirus matrix protein structures reveal a novel mode of self-association.

Authors:  Stephen C Graham; René Assenberg; Olivier Delmas; Anil Verma; Alireza Gholami; Chiraz Talbi; Raymond J Owens; David I Stuart; Jonathan M Grimes; Hervé Bourhy
Journal:  PLoS Pathog       Date:  2008-12-26       Impact factor: 6.823

7.  A mutant vesicular stomatitis virus with reduced cytotoxicity and enhanced anterograde trans-synaptic efficiency.

Authors:  Kunzhang Lin; Xin Zhong; Min Ying; Lei Li; Sijue Tao; Xutao Zhu; Xiaobin He; Fuqiang Xu
Journal:  Mol Brain       Date:  2020-03-20       Impact factor: 4.041

8.  SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.

Authors:  Lisa Miorin; Thomas Kehrer; Maria Teresa Sanchez-Aparicio; Ke Zhang; Phillip Cohen; Roosheel S Patel; Anastasija Cupic; Tadashi Makio; Menghan Mei; Elena Moreno; Oded Danziger; Kris M White; Raveen Rathnasinghe; Melissa Uccellini; Shengyan Gao; Teresa Aydillo; Ignacio Mena; Xin Yin; Laura Martin-Sancho; Nevan J Krogan; Sumit K Chanda; Michael Schotsaert; Richard W Wozniak; Yi Ren; Brad R Rosenberg; Beatriz M A Fontoura; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-23       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.